Cogent Biosciences, Inc. (NASDAQ:COGT – Get Rating) shares saw an uptick in trading volume on Friday . 757,585 shares changed hands during trading, an increase of 23% from the previous session’s volume of 615,026 shares.The stock last traded at $11.14 and had previously closed at $10.75. Wall Street Analysts Forecast Growth Several analysts have recently […]
Robert W. Baird assumed coverage on shares of Cogent Biosciences (NASDAQ:COGT – Get Rating) in a research report issued on Thursday, The Fly reports. The brokerage set an “outperform” rating on the technology company’s stock. A number of other research firms have also issued reports on COGT. HC Wainwright reissued a “buy” rating on shares […]
Cogent Biosciences, Inc. (NASDAQ:COGT – Get Rating) passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $12.64 and traded as low as $10.51. Cogent Biosciences shares last traded at $10.83, with a volume of 450,648 shares traded. Wall Street Analysts Forecast Growth COGT […]
HC Wainwright reissued their buy rating on shares of Cogent Biosciences (NASDAQ:COGT – Get Rating) in a research note released on Monday, PriceTargets.com reports. HC Wainwright also issued estimates for Cogent Biosciences’ Q1 2023 earnings at ($0.65) EPS, Q2 2023 earnings at ($0.67) EPS, Q3 2023 earnings at ($0.72) EPS, Q4 2023 earnings at ($0.73) […]
Boothbay Fund Management LLC reduced its stake in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Rating) by 41.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,752 shares of the technology company’s stock after selling 13,748 shares during the quarter. […]